Search Results - "WITTE, Robert S"

Topotecan in previously treated advanced urothelial carcinoma : an ECOG phase II trial by WITTE, R. S, MANOLA, J, BURCH, P. A, KUZEL, T, WEINSHEL, E. L, LOEHRER, P. J

“…[corrected] Chemotherapeutic agents are playing an increasing role in the management of urothelial carcinoma. Despite recent advances in the treatment of this…”
Get full text

Comparison of 5‐fluorouracil alone, 5‐fluorouracil with levamisole, and 5‐fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra‐abdominal metastasis after undergoing resection for colorectal carcinoma by Witte, Robert S., Cnaan, Avital, Mansour, Edward G., Barylak, Edward, Harris, Jules E., Schutt, Allan J.

“…BACKGROUND The authors conducted a randomized Phase III trial of three treatment regimens for patients with residual, nonmeasurable, intra‐abdominal metastatic…”
Get full text

Acute tumor lysis syndrome with choriocarcinoma by BLANKE, Charles D, HEMMER, Paul A, WITTE, Robert S

“…A 52-year-old man with retroperitoneal nodal, lung, and liver metastases from choriocarcinoma received chemotherapy with etoposide, cisplatin, and bleomycin…”
Get full text

A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancer by WITTE, R. S, LIPSITZ, S, GOODMAN, T. L, ASBURY, R. F, WILDING, G, STRNAD, C. M, SMITH, T. J, HALLER, D. G

“…Twenty-four previously untreated, ambulatory patients with advanced colorectal carcinoma were treated with either caracemide (11 patients) or homoharringtonine…”
Get full text

Acute Tumor Lysis Syndrome With Choriocarcinoma by BLANKE, CHARLES D., HEMMER, PAUL A., WITTE, ROBERT S.

Get full text

Long-term effects of patterned reward schedules by Witte, Robert S

“…Human Ss participated in a 2-choice probability-learning study spanning 5 experimental sessions. After being exposed to different reward patterns during an…”
Get full text

Conditional response probability in a T maze by Witte, Robert S

“…"A model derived from statistical learning theory was tested with rats in a T maze. The major independent variables were two sequentially dependent reward…”
Get full text

A stimulus-trace hypothesis for statistical learning theory by Witte, Robert S

“…According to the trace-fluctuation model, terminal estimates of conditional response probability should match the sequential dependencies between…”
Get full text

Concurrent conditioning of bar press and salivation responses by Kintsch, Walter, Witte, Robert S

“…The present investigation was designed to study the concurrent conditioning of salivation and bar pressing in surgically prepared dogs. Fixed-interval,…”
Get full text

Maintenance etidronate in the prevention of malignancy-associated hypercalcemia by Schiller, J H, Rasmussen, P, Benson, 3rd, A B, Witte, R S, Bockman, R S, Harvey, H A, Siris, E S, Citrin, D L, Greco, F A, Stock, J L

“…Normocalcemic patients with cancer who had been successfully treated for an episode of hypercalcemia were enrolled in a randomized, multisite, double-blind,…”
Get more information

An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma by Witte, R S, Elson, P, Khandakar, J, Trump, D L

“…Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder…”
Get more information

PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma by Witte, Robert S, Ryan, Louise M, Schutt, Allan J, Carbone, Paul P, Engstrom, Paul F

Get full text

A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer by WITTE, R. S, HSIEH, P, ELSON, P, OKEN, M. M, TRUMP, D. L

“…Forty-eight previously untreated, ambulatory patients with advanced or unresectable renal carcinoma were treated with either amonafide (17 patients),…”
Get full text

PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma by WITTE, R. S, RYAN, L. M, SCHUTT, A. J, CARBONE, P. P, ENGSTROM, P. F

“…Seventy-three eligible, chemotherapy-naive, ambulatory patients with advanced pancreatic carcinoma were allocated to one of two treatment regimens: 35 received…”
Get full text

A phase II trial of melphalan or thioguanine in the treatment of patients with advanced renal cell cancer by Witte, Robert S., Elson, Paul, Stewart, James A., Malliard, James A., Oken, Martin M., Loehrer, Patrick J.

“…Sixty-one ambulatory patients with advanced or unresectable renal carcinoma were treated with either melphalan (41 patients) or thioguanine (20 patients). Two…”
Get full text

Trimetrexate in advanced hormone-refractory prostate cancer : an ECOG phase II trial by WITTE, R. S, BEOW YONG YEAP, TRUMP, D. L

“…The antitumor activity and toxicity of trimetrexate (TMTX) was evaluated in measurable, hormone-refractory, advanced prostate cancer patients. Patients were…”
Get full text

A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma by WITTE, R. S, LEONG, T, ERNSTOFF, M. S, KRIGEL, R. L, OKEN, M. M, HARRIS, J, TORMEY, D. C, TRUMP, D. L

“…Biologic response modifiers have activity in renal cell carcinoma. The combination of interleukin-2 (IL-2) and beta-interferon (B-IFN) is synergistic in vitro…”
Get full text

Trimetrexate in advanced renal cell carcinoma : an ECOG phase II trial by WITTE, R. S, ELSON, P, BRYAN, G. T, TRUMP, D. L

“…Thirty-four chemotherapy-naive, ambulatory patients with advanced renal cell cancer were treated with the non-classical antifol trimetrexate at the intravenous…”
Get full text

Evaluation of deoxycoformycin in patients with advanced renal cell carcinoma : an ECOG pilot study by WITTE, R. S, WALSH, C, FISHER, H, OKEM, M. M, REDING, D. J, TRUMP, D. L

Get full text

A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effects by Witte, R S, Pruitt, B, Tormey, D C, Moss, S, Rose, D P, Falkson, G, Carbone, P P, Ramirez, G, Falkson, H, Pretorius, F J

“…Tamoxifen and trioxifene are antiestrogens that appear to have different endocrine effects when tested in rats. Whereas tamoxifen has considerable clinical…”
Get more information